Better Bonding Between U.S., Indian Regulators Can Ensure Good Quality Of Data From India's Clinical Trial Sites, Say Experts
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Select Indian clinical research organizations have called for greater collaboration between drug regulators in India and the U.S. to increase confidence about the quality and reliability of clinical trial data being increasingly generated at scores of Indian sites